Stock Comparison
Luzhou Laojiao Co., Ltd. vs AstraZeneca PLC
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Luzhou Laojiao Co., Ltd.
000568.SZ · Shenzhen Stock Exchange
Weighted across the company's segments.
Full stock profile
Dive deeper into Luzhou Laojiao Co., Ltd.'s moat claims, evidence, and risks.
View 000568.SZ analysisAstraZeneca PLC
AZN · London Stock Exchange
Weighted across the company's segments.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisComparison highlights
- Moat score gap: Luzhou Laojiao Co., Ltd. leads (73 / 100 vs 69 / 100 for AstraZeneca PLC).
- Segment focus: Luzhou Laojiao Co., Ltd. has 3 segments (87.9% in Mid- and high-end baijiu); AstraZeneca PLC has 6 segments (46% in Oncology).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Luzhou Laojiao Co., Ltd. has 2 moat types across 2 domains; AstraZeneca PLC has 1 across 1.
Primary market context
Luzhou Laojiao Co., Ltd.
Mid- and high-end baijiu
Mid- and high-priced baijiu in China, centered on strong-aroma products priced at least CNY150 per bottle
China (primarily); limited exports
Consumers buying for personal consumption, gifting, and banquets through distributors, retail, and e-commerce
Distiller, owner of National Cellar 1573 and Luzhou Laojiao brands, and supplier to authorized distributors
87.9%
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
46%
Side-by-side metrics
Moat coverage
Shared moat types
No overlap yet.
Luzhou Laojiao Co., Ltd. strengths
AstraZeneca PLC strengths
Segment mix
Luzhou Laojiao Co., Ltd. segments
Full profile >Mid- and high-end baijiu
Oligopoly
Other baijiu (mainstream/value)
Competitive
Other revenues
Competitive
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Infectious Disease
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
Act on this comparison
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.